Patents/Assignees

REMD Biotherapeutics, Inc.

3 patents in portfolio

US12617857utility2026
Chemokine Receptor 4 (CXCR4) Antagonist Antibodies
0 cites
US12606631utility2026
Antibodies Which Bind Human Endothelin Receptor a (ET a R)
0 cites
US11629184utility2023
Calcitonin Gene-related Peptide (CGRP) Antagonist Antibodies
0 cites